Our Current Portfolio at a Glance

Our EXIS™️ platform drives a portfolio of fully human antibody therapeutics across multiple disease areas. We are currently advancing candidates in Immunology & Inflammation, Obesity & Metabolic Disorders, and Oncology, with plans to expand into new indications.